Business Description
Jasper Therapeutics is a Redwood City, California-based company founded in 2018 that is working to bring new treatments to patients with serious blood and immune system disorders. Its main drug candidate, briquilimab, works by blocking a key signal that drives the growth of certain disease-causing cells in conditions such as chronic hives, asthma, and sickle cell disease. The company is also exploring how this same approach can help prepare patients for stem cell transplants, offering a potentially safer alternative to current methods.
